<level type="section">
  <num>7-2081.01</num>
  <heading>Definitions.</heading>
  <text>For the purpose of this chapter, the term:</text>
  <level>
    <num>(1)</num>
    <text>"Antimicrobial drug" means a drug identified in the most current guidelines for the treatment of sexually transmitted infections recognized by the Centers for Disease Control and Prevention.</text>
  </level>
  <level>
    <num>(2)</num>
    <text>"DOH" means the Department of Health.</text>
  </level>
  <level>
    <num>(3)</num>
    <text>"Expedited partner therapy" or "EPT" means when a health care practitioner who has diagnosed a sexually transmitted infection in a patient, prescribes and dispenses antimicrobial drugs to the patient's sexual partner for treatment of that sexually transmitted infection without an examination of the sexual partner.</text>
  </level>
  <level>
    <num>(4)</num>
    <text>"Health care practitioner" means a physician, advanced practice registered nurse, or physician's assistant authorized to diagnose and prescribe drugs for sexually transmitted infections.</text>
  </level>
  <level>
    <num>(5)</num>
    <text>"STI" means a sexually transmitted infection.</text>
  </level>
  <level type="annotations">
    <level>
      <heading>History</heading>
      <text>(Apr. 30, 2014, D.C. Law 20-97, ยง 2, 61 DCR 1589.)</text>
    </level>
    <level>
      <heading>Legislative History of Law 20-97</heading>
      <text>Law 20-97, the "Expedited Partner Therapy Act of 2014," was introduced in Council and assigned Bill No. 20-343. The Bill was adopted on first and second readings on January 7, 2014, and February 4, 2014, respectively. Signed by the Mayor on February 19, 2014 it was assigned Act No. 20-279 and transmitted to Congress for its review. D.C. Law 20-97 became effective on April 30, 2014.</text>
    </level>
  </level>
</level>
